N-acetylcysteine 1200 mg effervescent tablets

Reference Product:

Name of the product: Fluimucil 600

Name of the company: Zambon Spa

Patent expiry date: N/A

Dossier:

Language: English

Format: EU CTD

Registration:

Status: Evaluation on-going

Country: Portugal

Active substance:

Name: Acetylcysteine

Manufacturer: Moehs

DMF: Available

Finished product:

Strength, pharmaceutical form: 1200 mg, effervescent breakable tablets

Manufacturer: France

Industrial batch size: 100.000 tablets (can be raised to 300.000)

Packaging Option 1: Strips made of polyester/aluminium/polyethylene, containing 4 tablets.

Packaging, Option 2: Aluminium tube containing 10 tablets

Secondary packaging details: Box containing 3 strips

Comments

Add New Search RSS

Noel G. Lorica  - Business Development Manager   |2012-02-01 07:14:07 OEP Philippines is a leading Pharma company in the Philippines. We are looking for generic acetylcystein 600 mg effervescent tablet but can consider also breakable 1,2000 mg tablet. Reply

Alfredo Albuquerque  - interest   |2012-04-25 13:02:19 I'm interested in evaluating the business proposal for Portugal. Please contact me. Best regards Alfredo Reply

Alfredo Albuquerque  - interest   |2012-04-25 13:03:26 I'm interested in evaluating the business proposal for Portugal. Please send me further information Best regards Alfredo Reply

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Seborrhoeic dermatitis (10/01/2011)
• Acne (10/01/2011)
• Cimicifuga racemosa (10/01/2011)

• Lipogel for Elimination of Dark Skin Spots (08/02/2010)
• Ketoprofen (16/03/2009)
• Appetite suppressant with weight loss benifits (15/01/2009)
• Guidance and support to weight management (08/01/2009)
• Famotidine (27/08/2008)
• Diacerein (27/08/2008)
• Melatonin (27/08/2008)
• New oral care regimes (04/06/2008)
• Expert researchers in paracetamol activity (04/06/2008)